Japan health minister on new COVID-19 treatment
Japanese health minister Norihisa Tamura speaks to reporters in Tokyo on Sept. 27, 2021, after the government approved the use of Sotrovimab developed by GlaxoSmithKline plc and Vir Biotechnology Inc. as an antibody treatment for mild-to-moderate COVID-19 patients.
- Product Code
- ILEA000795275
- Registered date
- 2021/9/27 21:31:35
- Credit
- Kyodo / Kyodo News Images
- Media source
- 2021 Kyodo News
- Media size
- 3968 × 2527 pixel
- Deployment size
- 630.81(KB)*
*File size when opened in Photoshop, etc.